PD-L1 Biomarker Testing Market

Market Insights on PD-L1 Biomarker Testing covering sales outlook, demand forecast & up-to-date key trends

PD-L1 Biomarker Testing Market by Product, Indication, End User, Region | Forecast 2023 to 2033

PD – L1 Biomarker Testing Market Snapshot

The global PD – L1 biomarker testing market holds a valuation of US$ 597.9 Million by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 9.14%, and is expected to hold a market value of around US$ 1.58 Billion in 2033.

Market Outlook

Data Points	Market Insights
Market Value 2022	US$ 597.9 Million
Market Value 2023	US$ 659.6 Million
Market Value 2033	US$ 1.58 Billion
CAGR 2023 to 2033	9.14%
Market Share of Top 5 Countries (2022)	75.8%
Key Market Players	F. Hoffmann – La Roche Ltd., Agilent Technologies, Inc., Abcam plc, Shuwein Biotech Co. Ltd., NeoGenomics Laboratories, Inc., HalioDx, Abcam plc, Merck, Bristol-Myers Squibb, AstraZeneca

Cancer diagnostics involves detection of specific biomarkers, proteins, and symptoms of cancers in patients that indicate the development of abnormal cancerous cells. The detection make use of specific technology and devices used in its diagnosis. PD-L1 is a protein that helps to keep the immune system in check. In cancerous conditions, this protein is found in higher concentrations.

Cancer has a significant impact on society worldwide. It is one of the world's leading causes of death, with a higher prevalence in developed and emerging markets. According to the article published in a cancer journal for clinicians in 2021 regarding global cancer statistics 2020, International Agency for Research on Cancer estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020 in 185 countries. The alarming rise in cancer prevalence requires healthcare providers to reconsider cancer treatment goals and shift their focus to preventive care.

Rising research activities for the treatment of several cancer indications are expected to bode well for the market. Increasing applications of biomarker testing across abundant tumour types, including an earlier-stage cancer detection is anticipated to provide opportunities for key players to invest and research in the biomarker testing market. The innovation of biomarker testing is finding a new niche in cancer immunotherapy, which will help the market expand.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis from 2017 to 2022 Vs Market Outlook for 2023 to 2033 for PD – L1 Biomarker Testing Market

The PD – L1 biomarker testing market expanded at a CAGR of 6.96% between 2017 and 2022 due to increased awareness of cancer disease, advanced technologies used for cancer diagnosis.

The market value for PD-L1 biomarker testing market was around 1.0% of the overall US$ 67.2 Billion of the global diagnostic biomarkers market in 2022.

PD-L1 biomarker testing is a reliable diagnostic approach in cancer management since it is based on the fact that each person has distinctive levels of the PD-L1 protein. For instance, early stages of non-small cell lung cancer (NSCLC) and melanoma are found using PD-L1 biomarkers in cancer diagnoses and analysis.

The growing availability of high-quality immunotherapy products worldwide is addressing unmet cancer treatment needs. In the current scenario, lifestyle changes such as physical inactivity, tobacco consumption and smoking, as well as an unhealthy diet, are main contributors to the rising burden of cancerous indications.

Key market players are focusing on the development or extension of novel biologics using existing biologic resources for innovative product identification and the provision of patented therapies. Cancer immunotherapy has advanced the diagnostic approach to cancer detection and management, propelling the PD-L1 biomarker testing market forward.

H1-H2 Update

Market Statistics	Details
Jan to Jun (H1), 2021 (A)	8.30%
Jul to Dec (H2), 2021 (A)	12.06%
Jan to Jun (H1),2022 Projected (P)	8.27%
Jan to Jun (H1),2022 Outlook (O)	9.11%
Jul to Dec (H2), 2022 Outlook (O)	11.69%
Jul to Dec (H2), 2022 Projected (P)	11.06%
Jan to Jun (H1), 2023 Projected (P)	8.30%
BPS Change : H1,2022 (O) - H1,2022 (P)	85↑
BPS Change : H1,2022 (O) - H1,2021 (A)	82↑
BPS Change: H2, 2022 (O) - H2, 2022 (P)	63↑
BPS Change: H2, 2022 (O) - H2, 2022 (A)	(-) 37↓

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Key Drivers for PD – L1 Biomarker Testing Product Manufacturers?

Increasing number of cancer cases worldwide is the key driver to boost the global market. Cancer is at the second place for prevalence in the world. According to World Cancer Research Fund International, detected cancer cases were 18,094,716 million globally in 2020. Prevention of cancer is very challenging and needs an early detection.

The development of reliable PD-L1 biomarker testing with appropriate licensing for use is expected to drive PD-L1 biomarker testing sales in the coming years. Because of PD-L1 biomarker screening tests, the pharmacological diagnosis of cancer were possible. It is helping in production of personalised medicines, thus anticipated to increase the cancer screening biomarkers like PD-L1 biomarker.

The lifestyle choices, dietary habits, and social factors like drinking, smoking, and tobacco habits have dramatically increased in recent years all throughout the world, especially among younger generations. These factors directly adds to the rising incidence of lung cancer around the world. People's awareness of early detection and diagnosis of lung cancer has grown in recent years, and more people are undergoing such tests. This, too, is expected to benefit the market in the forecast period.

What are the Factors Restraining Demand for PD – L1 Biomarker Testing Products?

The challenges in testing and identifying biomarkers, as well as their validation and implementation in molecular diagnostics, are factors limiting the demand for PD-L1 biomarker testing. Trials including clone evolution, tumour heterogeneity detection, and biomarker testing are also likely to have a detrimental effect on market expansion.

The growth of the PD-L1 biomarker testing market is also hampered by the lack of skilled laboratory technicians because diagnostic laboratories use cutting-edge technology and automation. Despite the availability of advanced tools that make testing simple, critical mistakes regarding the dependability of data across multiple platform, as well as comparable difficulties in analytical validation, will affect sales.

Molecular testing faces considerable obstacles in several regions due to difficulties with regulatory authorities' drug licencing and testing procedures as well as the availability of constrained reimbursement. These characteristics favour on-demand testing, which is expected to restrain the market's expansion for PD-L1 biomarker testing in the years to come.

Country-wise Insights

Country	The USA
Market Share (2023)	54.3%
Market Share (2033)	57.4%
BPS Analysis	311
Country	The United kingdom
Market Share (2023)	6.8%
Market Share (2033)	7.3%
BPS Analysis	46
Country	Canada
Market Share (2023)	5.6%
Market Share (2033)	4.1%
BPS Analysis	-148
Country	Germany
Market Share (2023)	5.2%
Market Share (2033)	4.7%
BPS Analysis	-54
Country	China
Market Share (2023)	4.5%
Market Share (2033)	5.2%
BPS Analysis	70

What is Driving the USA Market?

In 2023, with 54.3% of the market share, the United States will dominate the global market. The country's high prevalence of lung cancer and related chronic illnesses, as well as rising investments in the production of cutting-edge medications, medical technology in the oncology market, and increasing attention on early cancer diagnosis will aid the USA market grow throughout the duration of the forecast period.

According to American Cancer Society, the estimated values for lung cancer in the USA in 2023 are 238,340 new cases of lung cancer about and about 127,070 deaths from lung cancer.

Why is the United kingdom Market Considered Lucrative?

TheUnited kingdom market is anticipated to expand at a 9.9% CAGR over the forecast period, accounting for a significant part of the market for increased PD-L1 testing in the Europe.

Sales in the market are expected to be boosted by the presence of governed predictive testing within the nation under national and regional regulations, awareness of early cancer diagnosis, and technological development. Increasing medical tourism in the United kingdom will further increase the demand for PD-L1 biomarker testing.

According to Cancer Research United kingdom, estimated 167,000 cancer deaths occur in the United kingdom each year due to the high frequency of the disease.

What Makes the China Market Attractive?

PD-L1 biomarker testing market in China will expand at a CAGR of 10.8% over the forecast period. The need for PD-L1 biomarker testing is being driven by an increase in cancer cases in the nation.

According statistical presentation by GLOBOCAN 2022, there were approximately 4,820,000 new cancer cases identified in China in 2022. Among this number, 2,625,070 men and 2,195,764 women were diagnosed. These metrics support the transitive efforts by the country to present biomarker testing into the overall healthcare structure.

Category-wise Insights

Which PD-L1 Biomarker Testing Product is Considered Highly Sought-After?

PD-L1 22C3 assay kit demand will hold 49.90% of the overall market share in 2023. Sales in this market will grow during the forecast period due to the efficiency of PD-L1 22C3 tests used in non-small cell lung cancer testing and patients' positive responses to immune checkpoint inhibitors.

Why are Sales of PD-L1 Biomarker Testing in NSCLC Rising?

Global demand for PD-L1 Biomarker Testing for NSCLC is growing as lung cancer incidence rises. In 2023, the category is set to hold 62.8% of the global market share, and it is anticipated that this pattern will hold in the upcoming years. The availability of PD-L1 protein is the only biomarker, which can guide treatment with immune checkpoint inhibitors in non-small cell lung cancer (NSCLC).

Which End User Benefits the Most by PD-L1 Biomarker Testing?

In terms of end users, 44.1% of the global market share in 2023 will be held by cancer research institutes. The study and development of innovative treatments for oncological purposes across various cancer research centers is gaining traction as the prevalence of cancer-related morbidity increases globally.

Comparative View of Adjacent PD – L1 Biomarker Testing Market

PD – L1 Biomarker Testing Market:

Attributes	PD – L1 Biomarker Testing Market
CAGR (2023 to 2033)	9.14%
Market Value (2023)	US$ 659.6 Million
Growth Factor	Increased awareness of cancer diagnosis, cancer diagnosis technological development, and increased biomarker testing utilization.
Key Market Trend	The development of reliable cancer screening and laboratory-based tests that provide timely diagnosis will benefit the market

PD1 Non-Small Cell Lung Cancer Treatment Market:

Attributes	PD1 Non-Small Cell Lung Cancer Treatment Market
CAGR (2023 to 2033)	8.51%
Market Value (2023)	US$ 26.96 Billion
Growth Factor	High growth is attributed to the growing patient population, expected entry of several drugs, and increasing investment by industry players in research and development of NSCLC therapy
Key Trend	Distinct clinical benefits offered by therapy such as minimal side effects along with availability of number of targeted therapeutics

Cardiac Biomarker Diagnostic Test Kits Market Snapshot:

Attributes	Cardiac Biomarker Diagnostic Test Kits Market Snapshot
CAGR (2023 to 2033)	5.0%
Market Value (2023)	US$ 1.89 Billion
Growth Factor	Growing prevalence of cardiac diseases, introducing new products and huge investments in research and development to develop advanced cardiac biomarkers
Key Trend	Favorable government initiatives, health professionals and private organizations are introducing and establishing diagnostic laboratories, collaborating with leading players

Competitive Landscape

The focus of key players is on the development and introduction of novel PD-L1 biomarkers for the treatment of various cancers. Market exclusivity and government incentives to promote new and innovative options for cancer treatment will create lucrative opportunities for market players.

Some recent developments include

In June 2020, Merck received the FDA approval for second application for KEYTRUDA® (pembrolizumab), for the treatment of patients of all age groups suffering from metastatic tumour mutational burden-high (TMB-H).
In May 2020, Agilent Technologies' PD-L1 IHC 28-8 pharmDx was approved by the FDA for diagnosis of NSCLC.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the PD-L1 Biomarker Testing market, which are available in the full report.

Report Scope as Per PD – L1 Biomarker Testing Industry Analysis

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2017 to 2022
Market Analysis	US$ Million for Value, and Units for Volume
Key Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, United kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Türkiye, South Africa and North Africa.
Key Market Segments Covered	Product, Type, Application, and Region
Key Companies Profiled	F. Hoffmann – La Roche Ltd. Agilent Technologies, Inc. Abcam plc, Shuwein Biotech Co. Ltd. NeoGenomics Laboratories, Inc. HalioDx, Abcam plc Merck, Bristol-Myers Squibb AstraZeneca
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing	Available upon Request

Key Market Segments Covered in PD – L1 Biomarker Testing Industry Research

By Product:

PD-L1 22C3 Assay Kit
PD-L1 28-8 Assay Kit
PD-L1 SP142 Assay Kit
PD-L1 263 Assay Kit

By Indication:

NSCLC
Melanoma
Renal Cell Carcinoma
Gastrointestinal tract Malignancy
Haematological Malignancies
Ovarian Cancer
Other

By End User:

Hospitals
Diagnostic Laboratories
Cancer Research Institutes

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)

Frequently Asked Questions

What is the global PD – L1 biomarker testing market worth in 2022?

The global PD – L1 biomarker testing market is worth US$ 597.9 Million in 2022 and is set to expand 2.4X over the next ten years.

What is the global market estimated to reach in 2023?

The estimated market size of PD – L1 biomarker testing sector is US$ 659.6 Million in 2023.

What is the global market valuation expected for 2033?

The PD – L1 biomarker testing market is expected to reach US$ 1.58 Billion by the end of 2033.

What value CAGR did the global market exhibit over the last five years?

The global market expanded at CAGR of around 6.9% over the last 5 years between 2017 and 2022.

What is the projected CAGR for the PD-L1 biomarker testing market from 2023 to 2033?

The global market is projected to expand at a CAGR of about 9.14% between 2023 and 2033.

Which are the top five countries driving demand for PD – L1 biomarker testing in 2022?

The USA, the United kingdom Canada, Germany, and China are expected to drive demand for PD – L1 biomarker testing contributing value share of 75.8% in 2022.

What is the North America market outlook for PD – L1 biomarker testing in 2023?

North America dominates the global market and is estimated to hold more than 59% revenue share in 2023.

Which are the key players of PD – L1 biomarker testing industry?

F. Hoffmann – La Roche Ltd., Agilent Technologies, Inc., Abcam plc, Shuwein Biotech Co. Ltd., NeoGenomics Laboratories, Inc., HalioDx, Abcam plc, Merck, Bristol-Myers Squibb, and AstraZeneca are the key players of in the global market.

What is the USA Market Outlook?

In 2023, with 54.3% of the market share, the United States will dominate the global market

Which PD-L1 biomarker testing product is considered highly sought-after?

PD-L1 22C3 assay kit demand will hold 49.90% of the overall market share in 2023.

Table of Content

1. Executive Summary | PD-L1 Biomarker Testing Market

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption/Usage Analysis

4.2. Key Promotional Strategies, by Manufacturers

4.3. Key Regulations

4.4. PESTEL Analysis

4.5. Porter’s Analysis

4.6. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Outlook

5.1.3. Global Diagnostic Biomarkers Overview

5.2. Forecast Factors - Relevance & Impact

5.2.1. Top Companies Historical Growth

5.2.2. New Product Launches and Approvals

5.2.3. Adoption rate of Cancer Immunotherapy

5.2.4. Increasing R&D Expenditure by Key Players

5.2.5. Strategic Collaborations among Players

5.2.6. Pipeline Assessment

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. By Product

6.1.2. By Indication

6.1.3. By End User

6.1.4. By Country

6.2. 2022 Market Scenario

7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033

7.1. Historical Market Volume (Units) Analysis, 2017 to 2022

7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

8.1. Regional Pricing Analysis By Material

8.2. Pricing Break-up

8.2.1. Manufacturer Level Pricing

8.2.2. Distributor Level Pricing

8.3. Global Average Pricing Analysis Benchmark

8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033

9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

9.2. 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022

10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033

10.3.1. PD – L1 22C3 Assay Kit

10.3.2. PD – L1 28 – 8 Assay Kit

10.3.3. PD – L1 SP142 Assay Kit

10.3.4. PD – L1 263 Assay Kit

10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Million) Analysis by Indication, 2017 to 2022

11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Indication, 2023 to 2033

11.3.1. NSCLS

11.3.2. Melanoma

11.3.3. Renal Cell Carcinoma

11.3.4. Gastrointestinal Tract Malignancy

11.3.5. Hematological Malignancies

11.3.6. Ovarian Cancer

11.3.7. Other

11.4. Market Attractiveness Analysis by Indication

12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022

12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033

12.3.1. Hospitals

12.3.2. Diagnostic Laboratories

12.3.3. Cancer Research Institutes

12.4. Market Attractiveness Analysis by End User

13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

13.1. Introduction / Key Findings

13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2017 to 2022

13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast by Region, 2023 to 2033

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. East Asia

13.3.5. South Asia

13.3.6. Oceania

13.3.7. Middle East and Africa

13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

14.1. Introduction

14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2017 to 2022

14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

14.3.1. By Country

14.3.1.1. USA

14.3.1.2. Canada

14.3.2. By Product

14.3.3. By Indication

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product

14.4.3. By Indication

14.4.4. By End User

14.5. Market Trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. USA Market

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Product

14.8.1.2.2. By Indication

14.8.1.2.3. By End User

14.8.2. Canada Market

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Product

14.8.2.2.2. By Indication

14.8.2.2.3. By End User

15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

15.1. Introduction

15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022

15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

15.3.1. By Country

15.3.1.1. Mexico

15.3.1.2. Brazil

15.3.1.3. Argentina

15.3.1.4. Rest of Latin America

15.3.2. By Product

15.3.3. By Indication

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product

15.4.3. By Indication

15.4.4. By End User

15.5. Market Trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. Mexico Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Product

15.8.1.2.2. By Indication

15.8.1.2.3. By End User

15.8.2. Brazil Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Product

15.8.2.2.2. By Indication

15.8.2.2.3. By End User

15.8.3. Argentina Market Analysis

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Product

15.8.3.2.2. By Indication

15.8.3.2.3. By End User

16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

16.1. Introduction

16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2017 to 2022

16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. United kingdom

16.3.1.5. Spain

16.3.1.6. BENELUX

16.3.1.7. Russia

16.3.1.8. Rest of Europe

16.3.2. By Product

16.3.3. By Indication

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product

16.4.3. By Indication

16.4.4. By End User

16.5. Market Trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. Germany Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Product

16.8.1.2.2. By Indication

16.8.1.2.3. By End User

16.8.2. Italy Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Product

16.8.2.2.2. By Indication

16.8.2.2.3. By End User

16.8.3. France Market Analysis

16.8.3.1. Introduction

16.8.3.2. Market Analysis and Forecast by Market Taxonomy

16.8.3.2.1. By Product

16.8.3.2.2. By Indication

16.8.3.2.3. By End User

16.8.4. United kingdom Market Analysis

16.8.4.1. Introduction

16.8.4.2. Market Analysis and Forecast by Market Taxonomy

16.8.4.2.1. By Product

16.8.4.2.2. By Indication

16.8.4.2.3. By End User

16.8.5. Spain Market Analysis

16.8.5.1. Introduction

16.8.5.2. Market Analysis and Forecast by Market Taxonomy

16.8.5.2.1. By Product

16.8.5.2.2. By Indication

16.8.5.2.3. By End User

16.8.6. BENELUX Market Analysis

16.8.6.1. Introduction

16.8.6.2. Market Analysis and Forecast by Market Taxonomy

16.8.6.2.1. By Product

16.8.6.2.2. By Indication

16.8.6.2.3. By End User

16.8.7. Russia Market Analysis

16.8.7.1. Introduction

16.8.7.2. Market Analysis and Forecast by Market Taxonomy

16.8.7.2.1. By Product

16.8.7.2.2. By Indication

16.8.7.2.3. By End User

17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

17.1. Introduction

17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022

17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. By Product

17.3.3. By Indication

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product

17.4.3. By Indication

17.4.4. By End User

17.5. Market Trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. China Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Product

17.8.1.2.2. By Indication

17.8.1.2.3. By End User

17.8.2. Japan Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Product

17.8.2.2.2. By Indication

17.8.2.2.3. By End User

17.8.3. South Korea Market Analysis

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. By Product

17.8.3.2.2. By Indication

17.8.3.2.3. By End User

18. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

18.1. Introduction

18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022

18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

18.3.1. By Country

18.3.1.1. India

18.3.1.2. Indonesia

18.3.1.3. Malaysia

18.3.1.4. Thailand

18.3.1.5. Rest of South Asia

18.3.2. By Product

18.3.3. By Indication

18.3.4. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Product

18.4.3. By Indication

18.4.4. By End User

18.5. Market Trends

18.6. Key Market Participants - Intensity Mapping

18.7. Drivers and Restraints - Impact Analysis

18.8. Country Level Analysis & Forecast

18.8.1. India Market Analysis

18.8.1.1. Introduction

18.8.1.2. Market Analysis and Forecast by Market Taxonomy

18.8.1.2.1. By Product

18.8.1.2.2. By Indication

18.8.1.2.3. By End User

18.8.2. Indonesia Market Analysis

18.8.2.1. Introduction

18.8.2.2. Market Analysis and Forecast by Market Taxonomy

18.8.2.2.1. By Product

18.8.2.2.2. By Indication

18.8.2.2.3. By End User

18.8.3. Malaysia Market Analysis

18.8.3.1. Introduction

18.8.3.2. Market Analysis and Forecast by Market Taxonomy

18.8.3.2.1. By Product

18.8.3.2.2. By Indication

18.8.3.2.3. By End User

18.8.4. Thailand Market Analysis

18.8.4.1. Introduction

18.8.4.2. Market Analysis and Forecast by Market Taxonomy

18.8.4.2.1. By Product

18.8.4.2.2. By Indication

18.8.4.2.3. By End User

19. Oceania Market 2017 to 2022 and Forecast 2023 to 2033

19.1. Introduction

19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2017 to 2022

19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

19.3.1. By Country

19.3.1.1. Australia

19.3.1.2. New Zealand

19.3.2. By Product

19.3.3. By Indication

19.3.4. By End User

19.4. Market Attractiveness Analysis

19.4.1. By Country

19.4.2. By Product

19.4.3. By Indication

19.4.4. By End User

19.5. Market Trends

19.6. Key Market Participants - Intensity Mapping

19.7. Drivers and Restraints - Impact Analysis

19.8. Country Level Analysis & Forecast

19.8.1. Australia Market Analysis

19.8.1.1. Introduction

19.8.1.2. Market Analysis and Forecast by Market Taxonomy

19.8.1.2.1. By Product

19.8.1.2.2. By Indication

19.8.1.2.3. By End User

19.8.2. New Zealand Market Analysis

19.8.2.1. Introduction

19.8.2.2. Market Analysis and Forecast by Market Taxonomy

19.8.2.2.1. By Product

19.8.2.2.2. By Indication

19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033

20.1. Introduction

20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2017 to 2022

20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

20.3.1. By Country

20.3.1.1. GCC Countries

20.3.1.2. Türkiye

20.3.1.3. North Africa

20.3.1.4. South Africa

20.3.1.5. Rest of Middle East and Africa

20.3.2. By Product

20.3.3. By Indication

20.3.4. By End User

20.4. Market Attractiveness Analysis

20.4.1. By Country

20.4.2. By Product

20.4.3. By Indication

20.4.4. By End User

20.5. Market Trends

20.6. Key Market Participants - Intensity Mapping

20.7. Drivers and Restraints - Impact Analysis

20.8. Country Level Analysis & Forecast

20.8.1. GCC Countries Market Analysis

20.8.1.1. Introduction

20.8.1.2. Market Analysis and Forecast by Market Taxonomy

20.8.1.2.1. By Product

20.8.1.2.2. By Indication

20.8.1.2.3. By End User

20.8.2. Türkiye Market Analysis

20.8.2.1. Introduction

20.8.2.2. Market Analysis and Forecast by Market Taxonomy

20.8.2.2.1. By Product

20.8.2.2.2. By Indication

20.8.2.2.3. By End User

20.8.3. South Africa Market Analysis

20.8.3.1. Introduction

20.8.3.2. Market Analysis and Forecast by Market Taxonomy

20.8.3.2.1. By Product

20.8.3.2.2. By Indication

20.8.3.2.3. By End User

20.8.4. North Africa Market Analysis

20.8.4.1. Introduction

20.8.4.2. Market Analysis and Forecast by Market Taxonomy

20.8.4.2.1. By Product

20.8.4.2.2. By Indication

20.8.4.2.3. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Share Analysis of Top Players

21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard

22.2. Competition Benchmarking

22.3. Competition Deep Dive

22.3.1. F. Hoffmann – La Roche Ltd.

22.3.1.1. Overview

22.3.1.2. Product Portfolio

22.3.1.3. Sales Footprint

22.3.1.4. Key Financials

22.3.1.5. SWOT Analysis

22.3.1.6. Key Developments

22.3.1.7. Strategy Overview

22.3.1.7.1. Marketing Strategy

22.3.1.7.2. Product Strategy

22.3.1.7.3. Channel Strategy

22.3.2. Agilent Technologies, Inc.

22.3.2.1. Overview

22.3.2.2. Product Portfolio

22.3.2.3. Sales Footprint

22.3.2.4. Key Financials

22.3.2.5. SWOT Analysis

22.3.2.6. Key Developments

22.3.2.7. Strategy Overview

22.3.2.7.1. Marketing Strategy

22.3.2.7.2. Product Strategy

22.3.2.7.3. Channel Strategy

22.3.3. Abcam plc

22.3.3.1. Overview

22.3.3.2. Product Portfolio

22.3.3.3. Sales Footprint

22.3.3.4. Key Financials

22.3.3.5. SWOT Analysis

22.3.3.6. Key Developments

22.3.3.7. Strategy Overview

22.3.3.7.1. Marketing Strategy

22.3.3.7.2. Product Strategy

22.3.3.7.3. Channel Strategy

22.3.4. Shuwein Biotech Co. Ltd.

22.3.4.1. Overview

22.3.4.2. Product Portfolio

22.3.4.3. Sales Footprint

22.3.4.4. Key Financials

22.3.4.5. SWOT Analysis

22.3.4.6. Key Developments

22.3.4.7. Strategy Overview

22.3.4.7.1. Marketing Strategy

22.3.4.7.2. Product Strategy

22.3.4.7.3. Channel Strategy

22.3.5. NeoGenomics Laboratories, Inc.

22.3.5.1. Overview

22.3.5.2. Product Portfolio

22.3.5.3. Sales Footprint

22.3.5.4. Key Financials

22.3.5.5. SWOT Analysis

22.3.5.6. Key Developments

22.3.5.7. Strategy Overview

22.3.5.7.1. Marketing Strategy

22.3.5.7.2. Product Strategy

22.3.5.7.3. Channel Strategy

22.3.6. HalioDx

22.3.6.1. Overview

22.3.6.2. Product Portfolio

22.3.6.3. Sales Footprint

22.3.6.4. Key Financials

22.3.6.5. SWOT Analysis

22.3.6.6. Key Developments

22.3.6.7. Strategy Overview

22.3.6.7.1. Marketing Strategy

22.3.6.7.2. Product Strategy

22.3.6.7.3. Channel Strategy

22.3.7. Abcam plc

22.3.7.1. Overview

22.3.7.2. Product Portfolio

22.3.7.3. Sales Footprint

22.3.7.4. Key Financials

22.3.7.5. SWOT Analysis

22.3.7.6. Key Developments

22.3.7.7. Strategy Overview

22.3.7.7.1. Marketing Strategy

22.3.7.7.2. Product Strategy

22.3.7.7.3. Channel Strategy

22.3.8. Merck

22.3.8.1. Overview

22.3.8.2. Product Portfolio

22.3.8.3. Sales Footprint

22.3.8.4. Key Financials

22.3.8.5. SWOT Analysis

22.3.8.6. Key Developments

22.3.8.7. Strategy Overview

22.3.8.7.1. Marketing Strategy

22.3.8.7.2. Product Strategy

22.3.8.7.3. Channel Strategy

22.3.9. Bristol-Myers Squibb

22.3.9.1. Overview

22.3.9.2. Product Portfolio

22.3.9.3. Sales Footprint

22.3.9.4. Key Financials

22.3.9.5. SWOT Analysis

22.3.9.6. Key Developments

22.3.9.7. Strategy Overview

22.3.9.7.1. Marketing Strategy

22.3.9.7.2. Product Strategy

22.3.9.7.3. Channel Strategy

22.3.10. AstraZeneca

22.3.10.1. Overview

22.3.10.2. Product Portfolio

22.3.10.3. Sales Footprint

22.3.10.4. Key Financials

22.3.10.5. SWOT Analysis

22.3.10.6. Key Developments

22.3.10.7. Strategy Overview

22.3.10.7.1. Marketing Strategy

22.3.10.7.2. Product Strategy

22.3.10.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 02: Global Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 03: Global Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 04: Global Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 05: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region

Table 06: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 07: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 08: North America Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 09: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 10: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 11: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 13: Latin America Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 14: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 15: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 17: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 18: Europe Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 19: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 20: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 21: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 22: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 23: East Asia Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 24: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 25: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 26: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 27: South Asia Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 28: South Asia Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 29: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 30: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 31: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 32: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 33: Oceania Market Volume (Units) Analysis 2017 to 2022 and Forecast 2017 to 2033 by Product

Table 34: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 35: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Table 36: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Country

Table 37: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 38: Middle East & Africa Market Volume (Units) Analysis 2017 to 2022 and Forecast 2023 to 2033 by Product

Table 39: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 by Indication

Table 40: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Volume (Units), 2017 to 2022

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 03: Global Market Value (US$ Million) Analysis, 2017 to 2022

Figure 04: Global Market Forecast & Y-o-Y Growth, 2023 to 2033

Figure 05: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022–2033

Figure 06: Global Market Value Share (%) Analysis 2023 and 2033, by Product

Figure 07: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Product

Figure 08: Global Market Attractiveness Analysis 2023 to 2033, by Product

Figure 09: Global Market Value Share (%) Analysis 2023 and 2033, by Indication

Figure 10: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Indication

Figure 11: Global Market Attractiveness Analysis 2023 to 2033, by Indication

Figure 12: Global Market Value Share (%) Analysis 2023 and 2033, by End User

Figure 13: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User

Figure 14: Global Market Attractiveness Analysis 2023 to 2033, by End User

Figure 15: Global Market Value Share (%) Analysis 2023 and 2033, by Region

Figure 16: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region

Figure 17: Global Market Attractiveness Analysis 2023 to 2033, by Region

Figure 18: North America Market Value (US$ Million) Analysis, 2017 to 2022

Figure 19: North America Market Value (US$ Million) Forecast, 2023-2033

Figure 20: North America Market Value Share, by Product (2023 E)

Figure 21: North America Market Value Share, by Indication (2023 E)

Figure 22: North America Market Value Share, by End User (2023 E)

Figure 23: North America Market Value Share, by Country (2023 E)

Figure 24: North America Market Attractiveness Analysis by Product, 2023 to 2033

Figure 25: North America Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 26: North America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 27: North America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 28: USA Market Value Proportion Analysis, 2022

Figure 29: Global Vs. USA Growth Comparison

Figure 30: USA Market Share Analysis (%) by Product, 2022 & 2033

Figure 31: USA Market Share Analysis (%) by Indication, 2022 & 2033

Figure 32: USA Market Share Analysis (%) by End User, 2022 & 2033

Figure 33: Canada Market Value Proportion Analysis, 2022

Figure 34: Global Vs. Canada. Growth Comparison

Figure 35: Canada Market Share Analysis (%) by Product, 2022 & 2033

Figure 36: Canada Market Share Analysis (%) by Indication, 2022 & 2033

Figure 37: Canada Market Share Analysis (%) by End User, 2022 & 2033

Figure 38: Latin America Market Value (US$ Million) Analysis, 2017 to 2022

Figure 39: Latin America Market Value (US$ Million) Forecast, 2023-2033

Figure 40: Latin America Market Value Share, by Product (2023 E)

Figure 40: Latin America Market Value Share, by Indication (2023 E)

Figure 41: Latin America Market Value Share, by End User (2023 E)

Figure 42: Latin America Market Value Share, by Country (2023 E)

Figure 43: Latin America Market Attractiveness Analysis by Product, 2023 to 2033

Figure 44: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 45: Latin America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 46: Latin America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 47: Mexico Market Value Proportion Analysis, 2022

Figure 48: Global Vs Mexico Growth Comparison

Figure 49: Mexico Market Share Analysis (%) by Product, 2022 & 2033

Figure 50: Mexico Market Share Analysis (%) by Indication, 2022 & 2033

Figure 51: Mexico Market Share Analysis (%) by End User, 2022 & 2033

Figure 52: Brazil Market Value Proportion Analysis, 2022

Figure 53: Global Vs. Brazil. Growth Comparison

Figure 54: Brazil Market Share Analysis (%) by Product, 2022 & 2033

Figure 56: Brazil Market Share Analysis (%) by Indication, 2022 & 2033

Figure 57: Brazil Market Share Analysis (%) by End User, 2022 & 2033

Figure 58: Argentina Market Value Proportion Analysis, 2022

Figure 59: Global Vs Argentina Growth Comparison

Figure 60: Argentina Market Share Analysis (%) by Product, 2022 & 2033

Figure 61: Argentina Market Share Analysis (%) by Indication, 2022 & 2033

Figure 62: Argentina Market Share Analysis (%) by End User, 2022 & 2033

Figure 63: Europe Market Value (US$ Million) Analysis, 2017 to 2022

Figure 64: Europe Market Value (US$ Million) Forecast, 2023-2033

Figure 65: Europe Market Value Share, by Product (2023 E)

Figure 66: Europe Market Value Share, by Indication (2023 E)

Figure 67: Europe Market Value Share, by End User (2023 E)

Figure 68: Europe Market Value Share, by Country (2023 E)

Figure 69: Europe Market Attractiveness Analysis by Product, 2023 to 2033

Figure 70: Europe Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 71: Europe Market Attractiveness Analysis by End User, 2023 to 2033

Figure 72: Europe Market Attractiveness Analysis by Country, 2023 to 2033

Figure 73: UK Market Value Proportion Analysis, 2022

Figure 74: Global Vs. UK Growth Comparison

Figure 75: UK Market Share Analysis (%) by Product, 2022 & 2033

Figure 76: UK Market Share Analysis (%) by Indication, 2022 & 2033

Figure 77: UK Market Share Analysis (%) by End User, 2022 & 2033

Figure 78: Germany Market Value Proportion Analysis, 2022

Figure 79: Global Vs. Germany Growth Comparison

Figure 80: Germany Market Share Analysis (%) by Product, 2022 & 2033

Figure 81: Germany Market Share Analysis (%) by Indication, 2022 & 2033

Figure 82: Germany Market Share Analysis (%) by End User, 2022 & 2033

Figure 83: Italy Market Value Proportion Analysis, 2022

Figure 84: Global Vs. Italy Growth Comparison

Figure 85: Italy Market Share Analysis (%) by Product, 2022 & 2033

Figure 86: Italy Market Share Analysis (%) by Indication, 2022 & 2033

Figure 87: Italy Market Share Analysis (%) by End User, 2022 & 2033

Figure 88: France Market Value Proportion Analysis, 2022

Figure 89: Global Vs France Growth Comparison

Figure 90: France Market Share Analysis (%) by Product, 2022 & 2033

Figure 91: France Market Share Analysis (%) by Indication, 2022 & 2033

Figure 92: France Market Share Analysis (%) by End User, 2022 & 2033

Figure 93: Spain Market Value Proportion Analysis, 2022

Figure 94: Global Vs Spain Growth Comparison

Figure 95: Spain Market Share Analysis (%) by Product, 2022 & 2033

Figure 96: Spain Market Share Analysis (%) by Indication, 2022 & 2033

Figure 97: Spain Market Share Analysis (%) by End User, 2022 & 2033

Figure 98: Russia Market Value Proportion Analysis, 2022

Figure 99: Global Vs Russia Growth Comparison

Figure 100: Russia Market Share Analysis (%) by Product, 2022 & 2033

Figure 101: Russia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 102: Russia Market Share Analysis (%) by End User, 2022 & 2033

Figure 103: BENELUX Market Value Proportion Analysis, 2022

Figure 104: Global Vs BENELUX Growth Comparison

Figure 105: BENELUX Market Share Analysis (%) by Product, 2022 & 2033

Figure 106: BENELUX Market Share Analysis (%) by Indication, 2022 & 2033

Figure 107: BENELUX Market Share Analysis (%) by End User, 2022 & 2033

Figure 108: East Asia Market Value (US$ Million) Analysis, 2017 to 2022

Figure 109: East Asia Market Value (US$ Million) Forecast, 2023-2033

Figure 110: East Asia Market Value Share, by Product (2023 E)

Figure 111: East Asia Market Value Share, by Indication (2023 E)

Figure 112: East Asia Market Value Share, by End User (2023 E)

Figure 113: East Asia Market Value Share, by Country (2023 E)

Figure 114: East Asia Market Attractiveness Analysis by Product, 2023 to 2033

Figure 115: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 116: East Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 117: East Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 118: China Market Value Proportion Analysis, 2022

Figure 119: Global Vs. China Growth Comparison

Figure 120: China Market Share Analysis (%) by Product, 2022 & 2033

Figure 121: China Market Share Analysis (%) by Indication, 2022 & 2033

Figure 122: China Market Share Analysis (%) by End User, 2022 & 2033

Figure 123: Japan Market Value Proportion Analysis, 2022

Figure 124: Global Vs. Japan Growth Comparison

Figure 125: Japan Market Share Analysis (%) by Product, 2022 & 2033

Figure 126: Japan Market Share Analysis (%) by Indication, 2022 & 2033

Figure 127: Japan Market Share Analysis (%) by End User, 2022 & 2033

Figure 128: South Korea Market Value Proportion Analysis, 2022

Figure 129: Global Vs South Korea Growth Comparison

Figure 130: South Korea Market Share Analysis (%) by Product, 2022 & 2033

Figure 131: South Korea Market Share Analysis (%) by Indication, 2022 & 2033

Figure 132: South Korea Market Share Analysis (%) by End User, 2022 & 2033

Figure 133: South Asia Market Value (US$ Million) Analysis, 2017 to 2022

Figure 134: South Asia Market Value (US$ Million) Forecast, 2023-2033

Figure 135: South Asia Market Value Share, by Product (2023 E)

Figure 136: South Asia Market Value Share, by Indication (2023 E)

Figure 137: South Asia Market Value Share, by End User (2023 E)

Figure 138: South Asia Market Value Share, by Country (2023 E)

Figure 139: South Asia Market Attractiveness Analysis by Product, 2023 to 2033

Figure 140: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 141: South Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 142: South Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 143: India Market Value Proportion Analysis, 2022

Figure 144: Global Vs. India Growth Comparison

Figure 145: India Market Share Analysis (%) by Product, 2022 & 2033

Figure 146: India Market Share Analysis (%) by Indication, 2022 & 2033

Figure 147: India Market Share Analysis (%) by End User, 2022 & 2033

Figure 150: Indonesia Market Value Proportion Analysis, 2022

Figure 151: Global Vs. Indonesia Growth Comparison

Figure 152: Indonesia Market Share Analysis (%) by Product, 2022 & 2033

Figure 153: Indonesia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 154: Indonesia Market Share Analysis (%) by End User, 2022 & 2033

Figure 155: Malaysia Market Value Proportion Analysis, 2022

Figure 156: Global Vs. Malaysia Growth Comparison

Figure 157: Malaysia Market Share Analysis (%) by Product, 2022 & 2033

Figure 158: Malaysia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 159: Malaysia Market Share Analysis (%) by End User, 2022 & 2033

Figure 160: Thailand Market Value Proportion Analysis, 2022

Figure 161: Global Vs. Thailand Growth Comparison

Figure 162: Thailand Market Share Analysis (%) by Product, 2022 & 2033

Figure 163: Thailand Market Share Analysis (%) by Indication, 2022 & 2033

Figure 164: Thailand Market Share Analysis (%) by End User, 2022 & 2033

Figure 165: Oceania Market Value (US$ Million) Analysis, 2017 to 2022

Figure 166: Oceania Market Value (US$ Million) Forecast, 2023-2033

Figure 167: Oceania Market Value Share, by Product (2023 E)

Figure 168: Oceania Market Value Share, by Indication (2023 E)

Figure 169: Oceania Market Value Share, by End User (2023 E)

Figure 170: Oceania Market Value Share, by Country (2023 E)

Figure 171: Oceania Market Attractiveness Analysis by Product, 2023 to 2033

Figure 172: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 173: Oceania Market Attractiveness Analysis by End User, 2023 to 2033

Figure 174: Oceania Market Attractiveness Analysis by Country, 2023 to 2033

Figure 175: Australia Market Value Proportion Analysis, 2022

Figure 176: Global Vs. Australia Growth Comparison

Figure 177: Australia Market Share Analysis (%) by Product, 2022 & 2033

Figure 178: Australia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 179: Australia Market Share Analysis (%) by End User, 2022 & 2033

Figure 180: New Zealand Market Value Proportion Analysis, 2022

Figure 181: Global Vs New Zealand Growth Comparison

Figure 182: New Zealand Market Share Analysis (%) by Product, 2022 & 2033

Figure 183: New Zealand Market Share Analysis (%) by Indication, 2022 & 2033

Figure 184: New Zealand Market Share Analysis (%) by End User, 2022 & 2033

Figure 185: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022

Figure 186: Middle East & Africa Market Value (US$ Million) Forecast, 2023-2033

Figure 187: Middle East & Africa Market Value Share, by Product (2023 E)

Figure 188: Middle East & Africa Market Value Share, by Indication (2023 E)

Figure 189: Middle East & Africa Market Value Share, by End User (2023 E)

Figure 190: Middle East & Africa Market Value Share, by Country (2023 E)

Figure 191: Middle East & Africa Market Attractiveness Analysis by Product, 2023 to 2033

Figure 192: Middle East & Africa Market Attractiveness Analysis by Indication 2023 to 2033

Figure 193: Middle East & Africa Market Attractiveness Analysis by End User 2023 to 2033

Figure 194: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033

Figure 195: GCC Countries Market Value Proportion Analysis, 2022

Figure 196: Global Vs GCC Countries Growth Comparison

Figure 197: GCC Countries Market Share Analysis (%) by Product, 2022 & 2033

Figure 198: GCC Countries Market Share Analysis (%) by Indication, 2022 & 2033

Figure 199: GCC Countries Market Share Analysis (%) by End User, 2022 & 2033

Figure 200: Türkiye Market Value Proportion Analysis, 2022

Figure 201: Global Vs. Türkiye Growth Comparison

Figure 202: Türkiye Market Share Analysis (%) by Product, 2022 & 2033

Figure 203: Türkiye Market Share Analysis (%) by Indication, 2022 & 2033

Figure 204: Türkiye Market Share Analysis (%) by End User, 2022 & 2033

Figure 205: South Africa Market Value Proportion Analysis, 2022

Figure 206: Global Vs. South Africa Growth Comparison

Figure 207: South Africa Market Share Analysis (%) by Product, 2022 & 2033

Figure 208: South Africa Market Share Analysis (%) by Indication, 2022 & 2033

Figure 209: South Africa Market Share Analysis (%) by End User, 2022 & 2033

Figure 210: North Africa Market Value Proportion Analysis, 2022

Figure 211: Global Vs North Africa Growth Comparison

Figure 212: North Africa Market Share Analysis (%) by Product, 2022 & 2033

Figure 213: North Africa Market Share Analysis (%) by Indication, 2022 & 2033

Figure 214: North Africa Market Share Analysis (%) by End User, 2022 & 2033